MSJAX Mutual Fund

MSJAX Mutual Fund (Global Endurance Portfolio - Class A) is managed by Morgan Stanley Investment Management. MSJAX expense ratio is 1.35%, holding 31 positions across sectors including Health Care, Materials, Consumer Discretionary. Inception date: 2018-12-31.

MSJAX performance shows a YTD return of 0.59%. The 1-year return is 4.58% and the 5-year return is -6.47%. MSJAX dividend yield stands at 0.22%, paid annually.

MSJAX top holdings include Victoria Plc (19.1%), Roivant Sciences Ltd. Common Shares (7.3%), Arbutus Biopharma Corp. (5.5%), Immunovant Inc (4.9%), Qxo, Inc. (4.8%). Go to all MSJAX holdings, MSJAX sectors, or MSJAX dividends.

MSJAX can be compared against other funds. Use MSJAX overlap to find shared positions, or MSJAX vs another fund for a side-by-side view. MSJAX alternatives are available via the screener, along with tax-loss harvesting opportunities.